Clene (CLNN) Research & Development (2020 - 2026)
Clene (CLNN) posted Research & Development of $3.5 million for Q2 2026, down 36.93% on a QoQ basis from $5.5 million in Q4 2025, and down 1.22% year-over-year from $3.5 million in Q2 2025.
Analysis
Clene (CLNN) Research & Development (2020 - 2026) Analysis & Trends
Clene has reported Research & Development for 7 years, with the latest figure at $3.5 million in Q2 2026.
- On a quarterly basis, Research & Development fell 1.22% year-over-year to $3.5 million in Q2 2026; TTM through Jun 2026 was $16.0 million, a 6.43% increase from a year earlier, with the FY2025 full-year figure at $14.0 million, down 30.15% from the prior year.
- Research & Development was $3.5 million for Q2 2026 at Clene, down from $5.5 million in the prior quarter.
- The five-year high for Research & Development was $9.2 million in Q2 2022, with the low at $1.5 million in Q1 2025.
- Average Research & Development over 5 years is $5.7 million, with a median of $5.9 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Research & Development surged 41.63% in 2022, then tumbled 74.77% in 2025.
- Over 5 years, Research & Development stood at $7.8 million in 2022, then slipped by 14.13% to $6.7 million in 2023, then dropped by 16.56% to $5.6 million in 2024, then retreated by 1.17% to $5.5 million in 2025, then plunged by 36.93% to $3.5 million in 2026.
- The last three Research & Development figures came in at $3.5 million (Q2 2026), $5.5 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 2.81 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | -2.60 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 394.92 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 516.95 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 146.30 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | 3.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.47 Mn |
| Dec 31, 2025 | 5.50 Mn |
| Sep 30, 2025 | 3.51 Mn |
| Jun 30, 2025 | 3.51 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 5.57 Mn |
| Sep 30, 2024 | 4.47 Mn |
| Jun 30, 2024 | 4.15 Mn |
| Mar 31, 2024 | 5.87 Mn |
| Dec 31, 2023 | 6.67 Mn |
| Sep 30, 2023 | 5.97 Mn |
| Jun 30, 2023 | 6.62 Mn |
| Mar 31, 2023 | 7.40 Mn |
| Dec 31, 2022 | 7.77 Mn |
| Sep 30, 2022 | 6.40 Mn |
| Jun 30, 2022 | 9.17 Mn |
| Mar 31, 2022 | 8.58 Mn |
| Dec 31, 2021 | 9.52 Mn |
| Sep 30, 2021 | 6.15 Mn |
| Jun 30, 2021 | 6.47 Mn |